⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523008 | 0.78 | — | — | |
| SCHEMBL152414 | 0.73 | — | — | |
| SCHEMBL311602 | 0.70 | — | — | |
| SCHEMBL2514270 | 0.69 | — | — | |
| SCHEMBL3624729 | 0.69 | — | — | |
| Iodide SCHEMBL28463288 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL29426653 | 0.68 | — | — | |
| SCHEMBL9261412 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL28763140 | 0.67 | — | — | |
| SCHEMBL3717135 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6589963-B2 | Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin | KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2003-07-08 | — | — | US | disclosed |
| US-20030027836-A1 | Novel heterocyclic compounds and salts thereof and medicinal use of the same | KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2003-02-06 | — | — | US | disclosed |
| EP-1236719-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF AND MEDICINAL USE OF THE SAME | Kyoto Pharmaceutical Industries, Ltd. (JP) | 2002-09-04 | — | — | EP | disclosed |
| US-4439433-A | CEPHALOSPORIN ANTIBIOTICS | ROUSSEL UCLAF (FR) | 1984-03-27 | — | — | US | disclosed |